Information  X 
Enter a valid email address

Hemogenyx Pharma PLC GBP0.01 (HEMO)

Date Time Source Announcement
30 Sep 2019 7:00 am
RNS
Half-year Report
12 Sep 2019 7:00 am
RNS
Hemogenyx scientific advisor receives Lasker Award
01 Aug 2019 7:00 am
RNS
Total Voting Rights
12 Jul 2019 7:00 am
RNS
CDX Patent Application
03 Jul 2019 7:00 am
RNS
Director/PDMR Shareholding
28 Jun 2019 12:19 pm
RNS
Result of AGM
24 Jun 2019 7:00 am
RNS
Development of ApbHC
12 Jun 2019 7:00 am
RNS
CDX Effective as Conditioning Therapeutic in vivo
05 Jun 2019 8:15 am
RNS
CDX Antibody is Effective against AML in vivo
30 May 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
CDX Antibody is Effective against ALL in vitro
28 May 2019 7:00 am
RNS
Posting of Annual Report and Notice of AGM
15 May 2019 7:00 am
RNS
Variation of Terms of Warrant Instrument
01 May 2019 7:00 am
RNS
Director/PDMR Shareholding
29 Apr 2019 3:10 pm
RNS
Final Results for the Year Ended 31 December 2018
30 Jan 2019 7:00 am
RNS
Presentation at Cancer Immunotherapy Conference
07 Jan 2019 7:00 am
RNS
Operations Update
20 Dec 2018 7:00 am
RNS
Directorate Change
05 Nov 2018 7:00 am
RNS
Directorate Change & Appointment
22 Oct 2018 7:00 am
RNS
Orgenesis collaboration for Hu-PHEC development
19 Oct 2018 7:00 am
RNS
Collaboration, License and Investment by Orgenesis
15 Oct 2018 7:00 am
RNS
Collaboration with Johnson & Johnson Innovation
28 Sep 2018 9:30 am
RNS
Half-year Report
  7:00 am
RNS
Change of Adviser
03 Sep 2018 7:00 am
RNS
Hemogenyx to present at Oxford conference
27 Jun 2018 11:39 am
RNS
Result of AGM
08 Jun 2018 7:00 am
RNS
Investor presentation
05 Jun 2018 6:05 pm
RNS
Posting of Annual Report & Notice of AGM
14 May 2018 7:00 am
RNS
Development Agreement
08 May 2018 7:00 am
RNS
Research Collaboration with Rockefeller University
30 Apr 2018 4:23 pm
RNS
Final Results
11 Apr 2018 5:15 pm
RNS
Director/PDMR Shareholding
03 Apr 2018 7:00 am
RNS
Directorate Change
14 Mar 2018 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
13 Mar 2018 7:00 am
RNS
Collaboration with major US biotechnology company
06 Mar 2018 7:00 am
RNS
Advisory Board Appointment
01 Mar 2018 7:00 am
RNS
Align Research Initiation of Coverage
27 Feb 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
26 Feb 2018 2:17 pm
RNS
Stmnt re Share Price Movement
12 Feb 2018 7:00 am
RNS
Director/PDMR Shareholding
07 Feb 2018 7:00 am
RNS
Director/PDMR Shareholding
11 Jan 2018 7:00 am
RNS
Hemogenyx Welcomes N.Y. Lt. Governor to its Labs
07 Dec 2017 12:16 pm
RNS
Result of AGM
  7:00 am
RNS
AGM Statement
20 Nov 2017 7:00 am
RNS
University of Oxford Collaboration
15 Nov 2017 7:00 am
RNS
Directorate Change
14 Nov 2017 7:00 am
RNS
Notice of AGM
13 Nov 2017 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Statement re Press Comment
30 Oct 2017 7:00 am
RNS
LakePharma appointed for lead product development
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t